P57KIP2 targeted disruption and beckwith‐wiedemann syndrome: Is the inhibitor just a contributor?
Abstract
Beckwith‐Wiedemann syndrome is a human congenital disorder characterized by a wide variety of growth abnormalities, including developmental defects and predisposition to certain tumors. Genetic evidence has suggested a role for p57KIP2, a member of a family of cell cycle inhibitory genes, in Beckwith‐Wiedemann syndrome. Two independent groups(1,2) have reported the generation and characterization of mice lacking functional p57KIP2, These mice demonstrate a number of abnormal phenotypes which overlap with, although do not completely recapitulate, Beckwith‐Wiedemann syndrome. These findings advance the molecular characterization of a human disorder, and provide insight into the interplay between regulation of cell division and development.Keywords
This publication has 36 references indexed in Scilit:
- Cyclins, cyclin‐dependent kinases and differentiationBioEssays, 1997
- A Syndrome of Multiorgan Hyperplasia with Features of Gigantism, Tumorigenesis, and Female Sterility in p27 -Deficient MiceCell, 1996
- Genomic Imprinting in Mice: Its Function and Mechanism1Biology of Reproduction, 1996
- Inhibitors of mammalian G1 cyclin-dependent kinases.Genes & Development, 1995
- Consequences of postnatally elevated insulin-like growth factor-II in transgenic mice: endocrine changes and effects on body and organ growthEndocrinology, 1994
- Mosaic uniparental disomy in Beckwith-Wiedemann syndrome.Journal of Medical Genetics, 1994
- Clinical features and natural history of Beckwith‐Wiedemann syndrome: presentation of 74 new casesClinical Genetics, 1994
- Imprinting: a gamete's point of viewTrends in Genetics, 1994
- Beckwith-wiedemann syndrome, tumourigenesis and imprintingCurrent Opinion in Genetics & Development, 1992
- Complete and incomplete forms of Beckwith-Wiedemann syndrome: Their oncogenic potentialThe Journal of Pediatrics, 1980